Multiple Sclerosis patient Jennifer chose DVC Stem for her third stem cell treatment. She wanted to visit a reputable and transparent clinic that would answer her questions about therapy as well as regularly follow up with her progress post-treatment.
January 14, 2021
Jan 14, 2021
Medical Director | DVC Stem
Multiple Sclerosis patient Jennifer chose DVC Stem for her third stem cell treatment.
Jennifer received 300 million mesenchymal stem cells derived from ethically donated full term human umbilical cords. These are some of the most potent stem cells in regenerative medicine and have been shown to have significant positive effects of a range of conditions. The cells are sourced from US-based, FDA-registered lab Vitro Biopharma, located in Golden, CO. The treatment is designed to target and reduce inflammation, promote tissue regeneration.
The video above showcases Jen's improvements after treatment. Her balance has improved, and months after treatment she is now able to perform single leg lifts (assisted) during physiotherapy. We look forward to hearing more about Jen's post-treatment progress.
My wife Jennifer Stergio Hall just finished her treatment and wow were we impressed. The facilities are very clean, the staff is extra friendly, professional, and willing to listen and answer questions. Dr. Kona was awesome as well, he truly believes in these treatments, and his confidence is comforting. We have been to another stem cell clinic and the two major differences are the amount of cell you receive, and this clinic does viability testing to verify the amount of cells you are receiving. If you are considering this treatment, then strongly consider DVC Stem. We are willing to answer any questions you may have if needed just send me a message - Ben (Jennifers husband)
Stem cell therapy for Multiple Sclerosis has demonstrated great potential. Culturally expanded mesenchymal stem cells derived from perinatal tissues may promote healing and repair in the body, there can be quite a significant regenerative increase in Multiple Sclerosis patients. Patients may be able to expect an increase in energy, flexibility, strength, mobility and control of basic function. Mesenchymal stem cells also have the ability to regulate the immune system. This ability may allow mesenchymal stem cells to control the body's immune response leading to a reduction in symptoms. Mesenchymal stem cells (MSCs) represent an attractive alternative to develop a cell-based therapy for Multiple Sclerosis.
Stem cell therapy is a non-invasive treatment that aims to replace damaged cells within the body. Mesenchymal stem cell therapy can be deployed systemically via IV or injected locally to target specific sites, depending on patient needs.
The therapeutic uses of stem cells as a potential therapy for a variety of diseases has been immensely explored, the number of clinical trials conducted with Mesenchymal Stem Cells has increased exponentially over the past few years. (1)
Stem cells have a unique, intrinsic property that attracts them to inflammation in the body. Studies have shown that stem cells can regenerate damaged or diseased tissues, reduce inflammation and modulate the immune system promoting better health and quality of life. Mesenchymal stem cells do this by influencing tissue repair via paracrine effects (cell signaling in order to change the behaviour of existing cells) or direct cell-to-cell contact.
"MSCs are able to migrate and seed specifically into damaged tissue sites, where they can differentiate into functional cells to replace damaged or diseased cells" (4)
(1) Mao, Fei, et al. “Mesenchymal Stem Cells and Their Therapeutic Applications in Inflammatory Bowel Disease.” Oncotarget, Impact Journals LLC, 6 June 2017, https://www.ncbi.nlm.nih.gov/pubmed/28402942.
About the author
Dr. Cona has been performing stem cell therapy for over 10 years. He is a member of the World Academy of Anti-Aging Medicine (WAAAM). He is also a recognized member of the British Medical Association, the General Medical Council (UK), the Caribbean College of Family Physicians, and the American Academy of Family Physicians. He is the Medical Director for DVC Stem a world-renowned stem cell therapy clinic located in Grand Cayman.
Are you a candidate for stem cell treatment?
Complete our brief online application to find out if our IRB-approved mesenchymal stem cell treatment is right for you.Apply for treatment
You might also like...
The borders of the Cayman Islands are in a phased reopening process, which will expand within the next couple of months. This means that the airport is open but travel must be approved by the Cayman Islands Government & all visitors must participate in a mandatory 10 - 14 day quarantine.
Stem cell therapy results have been extremely positive so far, with approximately 75% of Multiple Sclerosis patients reporting significant improvement within 3 months of treatment, and showing little to no signs of regression out to 18-24 months. Our full Multiple Sclerosis study results are expected to be published later this year.
New study has found mesenchymal stem cells to be both a safe and effective treatment option for stroke.
Are people with Multiple Sclerosis more prone to severe Coronavirus related illness? Having a compromised immune system could potentially increase one’s risk of developing severe Coronavirus symptoms. This article aims to answer this question as well as describe the actions MS patients should take to mitigate risk.
Explaining the relationship between stem cell therapy and Parkinson's.
DVC STEM, GRAND CAYMAN